Browsing by Author "Karunasena, V.M."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    The first case of introduced malaria in Sri Lanka after elimination: Approach by the Anti Malaria Campaign to prevent re-establishment of malaria
    (Sri Lanka Medical Association., 2019) Karunasena, V.M.; Marasinghe, M.M.M.B.; Amarasinghe, S.; Senaratne, P.A.S.; Hasantha, M.B.R.; Hevawitharana, M.
    INTRODUCTION & OBJECTIVES: Apart from imported malaria infections Sri Lanka has been free of malaria cases for the past six years after elimination until December 26th 2018, when the first introduced case was reported. This manuscript describes the probable index case and the introduced case of malaria, and actions taken to curtail the spread of transmission. METHODS: Detailed case investigations of the probable index and introduced cases were carried out and appropriate responses were mounted by the Anti Malaria Campaign (AMC). Genome sequencing was performed on parasites obtained from the two cases to determine relatedness of the two parasite isolates. RESULTS: An Indian employed at a construction site in Moneragala district, developed a Plasmodium vivax infection 23 days after arriving in Sri Lanka. Thirteen days later a Sri Lankan with no travel history to a malaria endemic country was diagnosed with P.vivax malaria following his visit to the same site. Multi-locus genome sequencing show that P. vivax strains obtained from these cases share 100% genetic identity at five loci of three polymorphic genes (CSP, MSPI and MSP3a genes), suggesting that both patients were infected with the same P.vivax strain. AMC mounted a rapid response including parasitological and entomological surveillance, active case detection, appropriate vector control measures and raising public and clinician awareness at relevant sites. CONCLUSION: An outbreak and the re-introduction of malaria to Sri Lanka from an index and introduced cases were prevented by prompt interventions which illustrate a very effective surveillance and response system.
  • Thumbnail Image
    Item
    Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka
    (BioMed Central., 2020) Marasinghe, M.M.; Karunasena, V.M.; Seneratne, A.S.; Herath, H.D.B.; Fernando, D.; Wickremasinghe, R.; Mendis, K.N.; Ranaweera, D.
    BACKGROUND: Following malaria elimination, Sri Lanka was free from indigenous transmission for six consecutive years, until the first introduced case was reported in December 2018. The source of transmission (index case) was a member of a group of 32 migrant workers from India and the location of transmission was their residence reporting a high prevalence of the primary vector for malaria. Despite extensive vector control the situation was highly susceptible to onward transmission if another of the group developed malaria. Therefore, Mass Radical Treatment (MRT) of the group of workers for Plasmodium vivax malaria was undertaken to mitigate this risk. METHOD: The workers were screened for malaria by microscopy and RDT, their haemoglobin level assessed, and tested for Glucose 6 phosphate dehydrogenase deficiency (G6PD) using the Care Start RDT and Brewers test prior to treatment with chloroquine (CQ) 25 mg/kg body weight (over three days) and primaquine (PQ) (0.25 mg/kg/day bodyweight for 14 days) following informed consent. All were monitored for adverse events. RESULTS: None of the foreign workers were parasitaemic at baseline screening and their haemoglobin levels ranged from 9.7-14.7 g/dl. All 31 individuals (excluding the index case treated previously) were treated with the recommended dose of CQ. The G6PD test results were inconclusive in 45% of the RDT results and were discrepant between the two tests in 31% of the remaining test events. Seven workers who tested G6PD deficient in either test were excluded from PQ and the rest, 24 workers, received PQ. No serious adverse events occurred. CONCLUSIONS: Mass treatment may be an option in prevention of reintroduction settings for groups of migrants who are likely to be carrying latent malaria infections, and resident in areas of high receptivity. However, in the case of Plasmodium vivax and Plasmodium ovale, a more reliable and affordable point-of-care test for G6PD activity would be required. Most countries which are eliminating malaria now are in the tropical zone and face considerable and similar risks of malaria re-introduction due to massive labour migration between them and neighbouring countries. Regional elimination of malaria should be the focus of global strategy if malaria elimination from countries is to be worthwhile and sustainable. KEYWORDS: G6PD; Malaria; Mass radical treatment; Migrant labour; Prevention of reintroduction.